|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
03.11.25 - 19:30
|
Kimberly-Clark to Buy Kenvue for $40B | Open Interest 11/03/2025 (Bloomberg)
|
|
|
Get a jump start on the US trading day with Matt Miller and Dani Burger on "Bloomberg Open Interest." Deals Monday! Kimberly-Clark scoops up Tylenol maker Kenvue to create a consumer products giant. Plus, tech giants Microsoft and Alphabet are making more deals to build out their AI infrastructure. Amazon inks a $38B deal with OpenAI for Nvidia chips. And the outlook for credit markets. PIMCO President Christian Stracke joins Bloomberg Open Interest to talk about the opportunities and risks ahead. (Source: Bloomberg)...
|
|
|
03.11.25 - 19:03
|
Hippocratic AI Raises $126 Million in Series C at $3.5 Billion Valuation Led by Avenir Growth to Expand Clinically Safe Generative AI Agents Across Healthcare (Business Wire)
|
|
|
The company raises funds to fuel expansion, M&A, product development, and international growth.PALO ALTO, Calif.--(BUSINESS WIRE)--#GenAI--Hippocratic AI, the global leader in safety-focused generative AI healthcare agents, today announced the close of its Series C financing, raising $126 million at a $3.5 billion valuation and bringing its total funding to $404 million.
The funding was led by Avenir Growth, a leader in supporting category defining companies in generative AI, with participation from new and existing investors, including CapitalG (Google's growth fund), General Catalyst, Andreessen Horowitz (a16z), Kleiner Perkins, Premji Invest, Universal Health Services (UHS), Cincinnati Children's Hospital Medical Center, WellSpan Health, John Doerr, Rick Klausner, and others.
In just 15 months since commercialization, the company has established partnerships with over 50 large health systems, payors, and pharma clients in 6 countries, built over 1000 clinical use cases, and completed over 115 million...
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
